These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 21375480)
121. New strategies in the development of antidepressants: towards the modulation of neuroplasticity pathways. Vidal R; Pilar-Cuéllar F; dos Anjos S; Linge R; Treceño B; Vargas VI; Rodriguez-Gaztelumendi A; Mostany R; Castro E; Diaz A; Valdizán EM; Pazos A Curr Pharm Des; 2011; 17(5):521-33. PubMed ID: 21375480 [TBL] [Abstract][Full Text] [Related]
122. Serotonin 5-HT4 receptors: A new strategy for developing fast acting antidepressants? Vidal R; Castro E; Pilar-Cuéllar F; Pascual-Brazo J; Díaz A; Rojo ML; Linge R; Martín A; Valdizán EM; Pazos A Curr Pharm Des; 2014; 20(23):3751-62. PubMed ID: 24180399 [TBL] [Abstract][Full Text] [Related]
123. Neural plasticity and proliferation in the generation of antidepressant effects: hippocampal implication. Pilar-Cuéllar F; Vidal R; Díaz A; Castro E; dos Anjos S; Pascual-Brazo J; Linge R; Vargas V; Blanco H; Martínez-Villayandre B; Pazos Á; Valdizán EM Neural Plast; 2013; 2013():537265. PubMed ID: 23862076 [TBL] [Abstract][Full Text] [Related]
124. Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression. Levy MJF; Boulle F; Steinbusch HW; van den Hove DLA; Kenis G; Lanfumey L Psychopharmacology (Berl); 2018 Aug; 235(8):2195-2220. PubMed ID: 29961124 [TBL] [Abstract][Full Text] [Related]
125. [Depression and neuroplasticity]. Pitchot W; Polis M; Belachew S; Ansseau M Rev Med Liege; 2008; 63(5-6):372-7. PubMed ID: 18669207 [TBL] [Abstract][Full Text] [Related]
126. [Depression and neuroplasticity. Interaction of nervous, endocrine and immune systems]. Cassano P; Argibay P Medicina (B Aires); 2010; 70(2):185-93. PubMed ID: 20447905 [TBL] [Abstract][Full Text] [Related]
127. [Mechanism of action of antidepressants and therapeutic perspectives]. Bourin M; David DJ; Jolliet P; Gardier A Therapie; 2002; 57(4):385-96. PubMed ID: 12422559 [TBL] [Abstract][Full Text] [Related]
128. Translating the promise of 5HT Murphy SE; de Cates AN; Gillespie AL; Godlewska BR; Scaife JC; Wright LC; Cowen PJ; Harmer CJ Psychol Med; 2021 May; 51(7):1111-1120. PubMed ID: 32241310 [TBL] [Abstract][Full Text] [Related]
129. Monoamine neurocircuitry in depression and strategies for new treatments. Hamon M; Blier P Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():54-63. PubMed ID: 23602950 [TBL] [Abstract][Full Text] [Related]
130. Serotonin receptors, type 4: a new hope? Lucas G Curr Drug Targets; 2009 Nov; 10(11):1085-95. PubMed ID: 19702554 [TBL] [Abstract][Full Text] [Related]
131. Neuroanatomical, Biochemical, and Functional Modifications in Brain Induced by Treatment with Antidepressants. Khushboo ; Siddiqi NJ; de Lourdes Pereira M; Sharma B Mol Neurobiol; 2022 Jun; 59(6):3564-3584. PubMed ID: 35352302 [TBL] [Abstract][Full Text] [Related]